In 1995, White & Meany, with other members of its trial team, won the first verdict in the United States against Dow Chemical Co. (a $14.2 Million dollar judgment) for its negligence in connection with the manufacturing and marketing of defective breast implants.

In 2001, Stewart White became a partner in the firm. During this period, White & Meany successfully represented clients in serious personal injury cases, as well as many people who were injured by the diet drugs Fen-Phen and Redux. In 2004, Peter Wetherall became the fourth partner, adding to the success of the firm, and the name became White Meany & Wetherall.